№ files_lp_4_process_2_87302
File format: docx
Character count: 6848
File size: 57 KB
Structured statement outlining the procedures, hazards, and control measures for high-risk construction activities at ABCD Industries, with assigned responsibilities and documented worker acknowledgment.
Year:
2023
Organization:
ABCD Industries
Principal Contractor:
Ausmar
Location:
Far-out QLD, Australia
Document Type:
Safe Work Method Statement (SWMS)
Work Activity:
High-risk construction tasks including work at heights, near water, trenches, and energized electrical installations
Author / Responsible Officer:
Fred Bloggs, Works Manager
Person Responsible for Compliance:
Joe Bloggs, Leading Hand
Date Provided to Principal Contractor:
3 February 2023
Workplace Health & Safety Measures:
Induction training, toolbox meetings, ongoing supervision, SWMS review and sign-off
High-Risk Tasks:
Falls from height, trench collapse, electrocution, drowning, structural collapse, silica dust exposure, mobile plant movement
Control Measures:
Scaffolding and temporary support, exclusion zones, personal protective equipment, traffic management, daily inspections, certified procedures
Consultation & Induction:
Workers trained, briefed on SWMS, signed acknowledgment
Review Date:
Ongoing as per work progress and SWMS revisions
Source Type:
Safety and regulatory compliance document
High-Risk Construction Work Location:
XXX, What Street, Suburb QLD 4510
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
United States
Topic:
Genomics, Genetics
Document Type:
Research Paper
Organization / Institution:
Rutgers University, NIH
Author:
Matteo Di Vincenzo, Thanavadee Prachason, Gaia Sampogna, Angelo Arias-Magnasco, Bochao Danae Lin, Lotta-Katrin Pries, Jim van Os, Bart P.F. Rutten, Ran Barzilay, Andrea Fiorillo, Sinan Guloksuz
Target Audience:
Researchers, Geneticists, Biologists
Period of Activity:
2023
Date of Approval:
N/A
Date of Changes:
N/A
Note:
Year
Topic:
Work safety, heights
Document type:
Template
Target audience:
Workers, safety managers
Year:
2024
Region / City:
Forest Hill, NSW
Topic:
Workplace Safety
Document Type:
Safety Work Method Statement
Organization / Institution:
Department of Defence
Author:
N/A
Target Audience:
Workers, Contractors, Project Supervisors
Period of Validity:
11/03/2024 to 11/03/2025
Approval Date:
N/A
Date of Revision:
N/A
Year:
2021
Region / City:
Southport
Topic:
Health and Safety Regulations
Document Type:
Checklist
Organization / Institution:
McNab
Author:
McNab
Target Audience:
Subcontractors, Contractors
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Document Type:
Safe Work Method Statement (SWMS) checklist
Purpose:
Risk assessment and control allocation for construction works
Scope:
All foreseeable OHS and environmental hazards associated with works
Project Fields:
Project name, Project number, ABN, Business address
High Risk Construction Activity:
Yes/No classification required
Risk Assessment Requirement:
Mandatory review prior to and during works
Review Frequency:
Minimum every 3 months; monthly for high risk activities
Legislation and Standards:
Applicable legislation, Australian Standards, codes of practice
Hierarchy of Control:
Elimination, Substitution, Isolation, Engineering, Administration, PPE (ALARP principle)
Approval Requirement:
LORAC representative approval required for high risk construction activities
Required Signatories:
Subcontractor/Works Supervisor, Site Superintendent/Supervisor, Foreman, Engineer, Project Leader/Construction Manager
Consultation Requirement:
All personnel involved in the works must be consulted
Training and Qualifications:
Evidence of required qualifications and specific training to be provided
Plant and Equipment:
Identification and inspection requirements
Materials:
Materials used and SDS requirement
Monitoring Responsibility:
Assigned responsible personnel
Revision Procedure:
All revisions must follow the same consultation and approval process
Risk Rating System:
Probability and consequence matrix with defined acceptability thresholds
Year:
2026
Region / City:
Australia
Topic:
Workplace Safety
Document Type:
Safety Work Method Statement
Author:
Peter
Target Audience:
Workers, safety officers
Period of Validity:
Ongoing
Approval Date:
2026-02-26
Amendment Date:
N/A
Year:
2026
Region / City:
Not specified
Subject:
Workplace safety, cleaning tasks, risk management
Document Type:
Safety procedure
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Cleaning staff, site managers
Effective Period:
Ongoing
Date of Approval:
Not specified
Date of Revision:
Not specified
Equipment Used:
Vacuum, general cleaning equipment
Materials Used:
Cleaning chemicals
PPE Used:
Gloves, safety goggles
Risk Assessment Method:
Likelihood and severity matrix
Controls Reviewed By:
Site Supervisor or Area Manager
Note:
Year
Region / city:
Canberra
Subject:
Anticoagulant medicines, High-Risk Medicines
Document type:
Procedure
Organization / institution:
Canberra Health Services
Target audience:
Health professionals involved in prescribing, dispensing, and administering anticoagulants
Context:
This document provides guidelines on the safe management of high-risk anticoagulant medicines in Canberra Health Services to prevent prescription, dispensing, and administration errors.
Note:
Year
Region / city:
Canberra
Topic:
High-Risk Medicines, Insulin Administration
Document Type:
Procedure
Institution:
Canberra Health Services
Target Audience:
CHS Employees (Medical, Nursing, Midwifery, Pharmacy, Allied Health)
Year:
2023
Region / City:
Victoria
Subject:
Medication Safety, High-Risk Medicines
Document Type:
Guidance
Organization:
Victorian Department of Health
Author:
eHealth High Risk Medicine Safety Advisory Group
Target Audience:
Healthcare professionals, Clinical staff
Period of validity:
Ongoing
Approval Date:
2023
Date of Changes:
None
Year:
Not specified
Region / City:
Australia
Topic:
Health, Safety, Environment
Document Type:
Framework / Policy Guidance
Organization:
Telstra
Audience:
Suppliers of services and high-risk products
Scope:
Suppliers of services and high-risk products to Telstra
References:
Telstra HSE Standards, AS/NZ 3745
Attachments:
Definitions (Attachment 1)
Requirements:
Legal and contractual obligations of suppliers, mandatory HSE elements including Asbestos, Gas Detection, Special Work Locations, Electromagnetic Energy
Emergency Planning:
Compliance with AS/NZ 3745 for facilities management
Monitoring:
Managed and reviewed by Telstra designated contact, network induction mandatory for suppliers and visitors
Risk Management:
Includes hazard identification, inspections, risk assessment, and control measures
Environmental Considerations:
Energy impact, recycling, waste management, visual and flora/fauna protection
Note:
Year
Subject:
Travel and safety regulations
Document Type:
Waiver Application
Organization / Institution:
University of Connecticut
Target Audience:
University students participating in travel programs
Year:
2024
Region / city:
Australia
Theme:
Medical devices, Clinical trials
Document type:
Guidance
Institution:
Therapeutic Goods Administration (TGA)
Target audience:
Clinical trial sponsors, Medical device manufacturers
Effective period:
From 20 March 2024
Approval date:
14 March 2024
Changes date:
14 March 2024
Document type:
Emergency rescue plan
Scope:
High-risk work activities
Related high-risk work:
Confined space entry; use of safety harness; excavation and trenching; energised fault finding
Emergency phone numbers:
000; 112; (07) 3270 4040
Country:
Australia
Region:
Queensland
Emergency communication:
Phone; radio channel (if applicable)
Rescue scenarios:
Engulfment; falls; hazardous atmosphere; hazardous chemicals; fire; electrical
Required rescue equipment:
Harness; first aid kit; breathing apparatus; rescue lines; stretchers; oxygen resuscitation equipment; tripod or davit; lighting; firefighting equipment; gas detector; defibrillator; ventilation equipment; crane
Participants:
Rescue party members; spotters; qualified rescuers
Preconditions:
Rescue equipment set up and tested prior to work; briefing completed before commencement
Intended audience:
Workers and rescue personnel involved in high-risk work
Year:
2021
Region / city:
Australia
Theme:
Biosecurity
Document type:
Regulatory list
Organization / institution:
Australian Government Department of Agriculture, Water and the Environment
Target audience:
Importers and stakeholders in agriculture and biosecurity
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Note:
Year
Contextual description:
A research paper providing advanced imaging analysis methods for refining risk assessment in high-risk neuroblastoma patients.
Document Type:
Category 1 submission for Authority Required (Written) listing
Medicine:
Eflornithine (Ifinwil®) 250 mg tablet
Active Ingredient:
Eflornithine (as hydrochloride)
Sponsor:
Norgine Pty Ltd
Regulatory Authority:
Therapeutic Goods Administration (TGA)
Advisory Body:
Pharmaceutical Benefits Advisory Committee (PBAC)
Program:
Section 100 – Highly Specialised Drugs Program
Schedule:
General Schedule (Code GE – Schedule 85)
Indication:
High-risk neuroblastoma in patients aged 1 year and older in remission after prior therapy
Population:
Patients ≥1 year with high-risk neuroblastoma meeting INRG, COG, or SIOPEN criteria
Treatment Phase:
Initial and Continuing Treatment
Comparator:
Standard of care (follow-up and monitoring)
Clinical Outcomes:
Event-free survival, overall survival, safety
Dosage Form:
250 mg oral tablet
Treatment Duration:
Up to 27 cycles (2 years) or until disease progression
Orphan Drug Designation:
Granted 7 December 2022
Submission Pathway:
TGA/PBAC Parallel Process
Restriction Type:
Authority Required (Full assessment – written)
Prescriber Type:
Medical Practitioners (paediatric oncologist or haematologist for initiation)
Year:
2023
Region / City:
N/A
Subject:
Medical Research
Document Type:
Research Supplementary Figures
Institution:
N/A
Author:
N/A
Target Audience:
Medical Professionals
Action Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Context:
A set of supplementary figures for a study on the risk of Major Adverse Cardiovascular and Cerebrovascular Events (MACCEs) based on high-risk threshold values of hs-CRP and LDL-C, categorizing patients by these values and analyzing survival outcomes.